Search

Your search keyword '"Armero, Y."' showing total 38 results

Search Constraints

Start Over You searched for: Author "Armero, Y." Remove constraint Author: "Armero, Y."
38 results on '"Armero, Y."'

Search Results

1. Impact of High-Level Daptomycin Resistance in the Streptococcus mitis Group on Virulence and Survivability during Daptomycin Treatment in Experimental Infective Endocarditis

4. Antimicrobial management of Tropheryma whipplei endocarditis: the Spanish Collaboration on Endocarditis (GAMES) experience

5. Impact of early valve surgery on outcome of staphylococcus aureus prosthetic valve infective endocarditis: Analysis in the international collaboration of endocarditis-prospective cohort study.

6. Candida infective endocarditis: An observational cohort study with a focus on therapy.

7. Early in vitro development of daptomycin non-susceptibility in high-level aminoglycoside-resistant Enterococcus faecalis predicts the efficacy of the combination of high-dose daptomycin plus ampicillin in an in vivo model of experimental endocarditis.

8. One-year outcome following biological or mechanical valve replacement for infective endocarditis.

9. Influence of the timing of cardiac surgery on the outcome of patients with infective endocarditis and stroke.

10. HACEK Infective Endocarditis: Characteristics and Outcomes from a Large, Multi-National Cohort.

11. HACEK Infective Endocarditis: Characteristics and Outcomes from a Large, Multi-National Cohort

12. Non-HACEK gram-negative bacillus endocarditis.

13. Daptomycin Is Effective for Treatment of Experimental Endocarditis Due to Methicillin-Resistant and Glycopeptide-Intermediate Staphylococcus epidermidis

14. Addition of Gentamicin or Rifampin Does Not Enhance the Effectiveness of Daptomycin in Treatment of Experimental Endocarditis Due to Methicillin-Resistant Staphylococcus aureus

15. 084 TRENDS IN GLYCOPEPTIDE AND DAPTOMYCIN SUSCEPTIBILITIES IN STAPHYLOCOCCUS EPIDERMIDIS ISOLATED FROM INFECTIVE ENDOCARDITIS (IE) OVER TIME (1992 2008)

16. 047 DAPTOMYCIN IN THE TREATMENT OF EXPERIMENTAL ENDOCARDITIS (EE) DUE TO METHICILLIN-RESISTANT STAPHYLOCOCCUS EPIDERMIDIS (MRSE)

17. Fosfomycin plus β-Lactams as Synergistic Bactericidal Combinations for Experimental Endocarditis Due to Methicillin-Resistant and Glycopeptide-Intermediate Staphylococcus aureus

18. Cryopreserved mitral homograft in the tricuspid position for infective endocarditis: A valve that can be repaired in the long term (13 years)

19. Non-HACEK gram-negative bacillus endocarditis

20. Cryopreserved mitral homograft in the tricuspid position for infective endocarditis

21. Carta Esférica de la Costa de Cantabria desde Cabo Ortegal al rio Adour [Material cartográfico]

22. Voto particular sobre dotacion del culto y clero, y Discurso en sustentacion del mismo voto, pronunciado en el Congreso de los Diputados en la sesion del dia 10 de Junio de 1840

23. Carta Esférica de la Costa de Cantabria desde Cabo Ortegal al rio Adour [Material cartográfico]

24. [Papeles varios]

28. Reglas aprobadas por S.M. segun Real Orden de esta fecha, para la remesa, y subasta y remate de la impresión y venta de los Almanaques civiles de la península é Islas Adyacentes, formados en el Observatorio astronómico de Marina de la ciudad de San Fernando, en virtud de la facultad exclusiva que para ello le está concedida ..

29. Impact of High-Level Daptomycin Resistance in the Streptococcus mitisGroup on Virulence and Survivability during Daptomycin Treatment in Experimental Infective Endocarditis

30. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study

31. AUC/MIC Pharmacodynamic Target Is Not a Good Predictor of Vancomycin Efficacy in Methicillin-Resistant Staphylococcus aureus Experimental Endocarditis.

32. Epidemiology and prognosis of coagulase-negative staphylococcal endocarditis: impact of vancomycin minimum inhibitory concentration.

33. Effect of vancomycin minimal inhibitory concentration on the outcome of methicillin-susceptible Staphylococcus aureus endocarditis.

34. Early in vitro and in vivo development of high-level daptomycin resistance is common in mitis group Streptococci after exposure to daptomycin.

35. High-dose daptomycin plus fosfomycin is safe and effective in treating methicillin-susceptible and methicillin-resistant Staphylococcus aureus endocarditis.

36. Daptomycin is effective in treatment of experimental endocarditis due to methicillin-resistant and glycopeptide-intermediate Staphylococcus aureus.

37. Success of ampicillin plus ceftriaxone rescue therapy for a relapse of Enterococcus faecalis native-valve endocarditis and in vitro data on double beta-lactam activity.

38. Efficacy of telavancin in the treatment of experimental endocarditis due to glycopeptide-intermediate Staphylococcus aureus.

Catalog

Books, media, physical & digital resources